Medical Oncologist
CION Cancer Clinics
TACE vs TARE: how the choice between them is made | CION Cancer Clinics
Neither TACE nor TARE (Y-90) is better for everyone. Both treat liver cancer through the artery that feeds it: TACE delivers chemotherapy and blocks the vessel, TARE delivers tiny radioactive beads. The choice depends on where the tumours are, whether the portal vein is involved, how well your liver works, and what is available and affordable. This page explains how doctors weigh those things. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Is TACE or TARE better for liver cancer?
- How do TACE and TARE differ in practice?
- What makes doctors lean towards one or the other?
- What happens between the scan and the procedure?
- What do families often get wrong about TACE and Y-90?
- When is neither TACE nor TARE the right choice?
- What this page cannot tell you
- Common questions about TACE and TARE
The short answer
Is TACE or TARE better for liver cancer?
Neither is better for everyone. Studies comparing them have not shown one clearly helping people live longer than the other, so the choice rests on your tumour, your liver and practical matters such as availability and cost.
What the two words mean
Both are done by an interventional radiologist, who passes a thin tube from an artery in the groin or wrist into the artery feeding the tumour. In TACE (transarterial chemoembolisation), chemotherapy is delivered and the vessel is then blocked, starving the tumour. In TARE (transarterial radioembolisation), also called Y-90 or SIRT, millions of tiny beads carrying radioactive yttrium are delivered, and they give off radiation from inside the tumour.
Who this page is for
It is mainly about primary liver cancer, hepatocellular carcinoma (HCC). If your liver tumours spread from the bowel, the choices are different and are covered under colon cancer spread to the liver.
CION's tumour board advises on the choice. Both procedures are coordinated through accredited partner hospitals.Side by side
How do TACE and TARE differ in practice?
TACE
TARE (Y-90)
Chemotherapy plus blocking the blood supply
Radiation from tiny beads lodged in the tumour
Usually one procedure, often repeated later
A mapping procedure first, then the treatment on a later day
Pain, fever and nausea afterwards are common
Tiredness is common; pain and fever are usually milder
Often avoided when the main portal vein is blocked by tumour
Can be considered in some people with portal vein involvement
Widely available in Hyderabad and the districts
Offered at fewer centres in India and depends on imported material
Lower cost per procedure
Considerably higher cost, quoted separately
What tips the decision
What makes doctors lean towards one or the other?
The tumour board looks at the same scan and asks a few practical questions.
The portal vein
The portal vein brings most of the liver's blood. If tumour has grown into it, blocking the artery as well can starve healthy liver. TARE blocks the vessel much less, so it is sometimes preferred here.
Size and number of tumours
One large tumour, or tumours confined to one side of the liver, may suit TARE well. Several medium tumours across the liver are often treated with TACE, sometimes in stages.
Liver function
Both need a liver that is working reasonably well. A high bilirubin or fluid in the abdomen (ascites) can rule out either one.
What comes next
If the plan is to shrink a tumour before surgery or to hold it before a transplant, the team picks the treatment most likely to keep that next step open.
Also weighed
- Blood flow from the liver to the lungs
- Kidney function, for the contrast dye
- Cost and travel for repeat visits
Not sure whether this applies to you?
Ask an oncologistHow it is decided
What happens between the scan and the procedure?
A full set of scans
A triple-phase CT or MRI shows every tumour, its blood supply and the portal vein. Blood tests check liver and kidney function.
Tumour board discussion
Oncologists, surgeons and radiologists agree whether surgery, ablation, TACE, TARE or a drug suits you, and in what order.
For TARE, a mapping procedure
A test run checks the arteries and measures how much blood shunts from the liver to the lungs. Too much can rule TARE out. The lung shunting page explains why.
A written plan and estimate
You are told which procedure, where it takes place, and the cost. Ask for an itemised estimate before you agree.
Commonly believed
What do families often get wrong about TACE and Y-90?
"Y-90 costs more, so it must work better."
The cost reflects the imported material and the extra mapping step. It does not mean better results. For many tumours TACE is just as reasonable a choice.
"Radiation inside the body makes you dangerous to family."
The radiation stays almost entirely inside the liver and fades over a short time. You will be given simple precautions, such as limiting close contact with small children and pregnant women for a while.
"If TACE was offered, Y-90 was not considered."
Often both were weighed and TACE simply fitted better. It is fair to ask your doctor why one was chosen over the other.
"Once you have one, you can never have the other."
Some people have TACE first and TARE later, or the other way round, if the liver stays strong enough. It depends on how the liver copes.
Who this does not suit
When is neither TACE nor TARE the right choice?
Some people should not have either procedure. If the liver is failing, with deep jaundice, fluid in the abdomen that keeps coming back, or confusion from liver disease, both can make things worse. Then care focuses on comfort and on the liver itself.
When something else fits better
A single small tumour is often better treated by removing it, burning it with ablation, or a transplant, which aim to remove the cancer completely. If the cancer has spread outside the liver, a drug treatment such as atezolizumab plus bevacizumab usually comes first, because procedures only reach the liver.
Pregnancy and other illnesses
TARE is not given in pregnancy. Severe kidney disease, an allergy to contrast dye or a bleeding problem may affect both. Tell your team about every illness and medicine you have.
Being straight with you
What this page cannot tell you
It cannot tell you which procedure suits your tumour. That needs someone who has looked at your actual scans, especially the arteries and the portal vein, and your blood results. It also cannot predict how well either will work for you.
Where to read more
The step-by-step technique of each procedure is explained on the TACE vs TARE procedure page and the Y-90 radioembolisation page. Insurance cover differs between the two, and scheme rules change, so check at the time you are treated.
If you have been offered one procedure and want to know whether the other was considered, bring your scans for a second opinion.Questions we are asked
Common questions about TACE and TARE
Which is safer, TACE or TARE?
Both are generally safe in a well-chosen patient, and both carry risks to the liver. TARE tends to cause fewer pain and fever symptoms, while TACE has longer experience behind it. The safer choice is the one that fits your liver function and tumour, which your team will explain.
Do I need to stay in hospital?
Many people stay one night after TACE because of pain and fever. TARE is often done with a short stay or as a day procedure. The partner hospital will tell you what to expect and whether a family member should stay with you.
Why does Y-90 need two procedures?
The first is a mapping run. It checks that the beads will go only where they should and that too much blood does not flow from the liver to the lungs. Some arteries may be closed off at this stage to protect the stomach and bowel.
Is Y-90 available in Hyderabad?
It is offered at a smaller number of hospitals than TACE, and depends on imported radioactive material that must be scheduled in advance. Your CION team can tell you where it is available and coordinate the referral if it is the right choice for you.
Can either one remove the cancer completely?
Occasionally a tumour disappears on scans, but both are usually aimed at control. They are mainly used when surgery, ablation or a transplant is not possible, or to hold or shrink a tumour before one of those. Your team will tell you the aim in your case.
Can I have either with hepatitis B?
Yes, usually, once the virus is controlled. These procedures can stir up the virus, so your viral load is checked and antiviral tablets are started or continued. Hepatitis B is controlled rather than removed, so keep taking them as advised.
Can a drug be combined with either procedure?
Sometimes. Targeted tablets and immunotherapy are being studied with both. Whether a drug should be added depends on your stage and liver. The page on TACE with systemic treatment explains how that decision is made.
How do I get a second opinion on the choice?
Bring your scan discs, reports, liver blood tests and the doctor's recommendation to a CION oncologist. The case can be discussed at the tumour board, and you will be told which procedure suits you, why, and what the alternatives are.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Embolization Therapy for Liver Cancer
- RadiologyInfo.org (RSNA/ACR) — TACE Cancerous Tumor Therapy
- RadiologyInfo.org (RSNA/ACR) — Radioembolization (Y90)
- EASL — EASL Clinical Practice Guidelines: management of hepatocellular carcinoma
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
How Radioembolisation Differs From TACEThe two procedures, compared on the day itselfIs Y-90 Worth the Cost Compared With TACE?The money question families ask nextWho Is Suitable for TACE?The checks that decide whether TACE is safe for youTACE Combined With Tablets or ImmunotherapyWhen a drug is added to the procedure
Talk to us
Offered TACE or Y-90 and not sure which?
Send us your scans and reports, and a CION oncologist will explain which option fits your tumour and your liver, and why. One helpline serves every CION centre.